NeuroPace (NPCE) Operating Margin (2020 - 2026)
NeuroPace's (NPCE) quarterly Operating Margin came in at 25.23% in Q1 2026, down 238.0% year-on-year from 18.28% in Q1 2025, and down 279.65% quarter-over-quarter from 6.65% in Q4 2025.
NeuroPace (NPCE) Operating Margin (2020 - 2026) Analysis & Trends
NeuroPace's Operating Margin history runs 7 years deep, the most recent figure standing at 25.23% for Q1 2026.
- On a quarterly basis, Operating Margin fell 238.0% year-over-year to 25.23% in Q1 2026; TTM through Mar 2026 was 16.84%, a 602.0% increase from a year earlier, with the FY2025 full-year figure at 16.34%, up 1078.0% from the prior year.
- Operating Margin slipped to 25.23% in Q1 2026 per NPCE's latest filing, from 6.65% in the prior quarter.
- Across five years, Operating Margin topped out at 6.65% in Q4 2025 and bottomed at 107.59% in Q2 2022.
- The 5-year median for Operating Margin is 32.35% (2024), against an average of 43.27%.
- Across the five-year window, Operating Margin plunged 7113 bps in 2022 and jumped 6002 bps in 2023, its largest moves.
- Year by year, Operating Margin stood at 77.09% in 2022, then soared by 64 bps to 28.04% in 2023, then soared by 39 bps to 17.02% in 2024, then surged by 61 bps to 6.65% in 2025, then slumped by 280 bps to 25.23% in 2026.
- Per Business Quant, the three latest NPCE Operating Margin figures stand at 25.23% (Q1 2026), 6.65% (Q4 2025), and 9.51% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | -25.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.23% |
| Dec 31, 2025 | -6.65% |
| Sep 30, 2025 | -9.51% |
| Jun 30, 2025 | -29.01% |
| Mar 31, 2025 | -22.85% |
| Dec 31, 2024 | -17.02% |
| Sep 30, 2024 | -20.15% |
| Jun 30, 2024 | -32.35% |
| Mar 31, 2024 | -41.63% |
| Dec 31, 2023 | -28.04% |
| Sep 30, 2023 | -36.22% |
| Jun 30, 2023 | -47.57% |
| Mar 31, 2023 | -57.48% |
| Dec 31, 2022 | -77.09% |
| Sep 30, 2022 | -91.41% |
| Jun 30, 2022 | -107.59% |
| Mar 31, 2022 | -85.83% |
| Dec 31, 2021 | -81.98% |
| Sep 30, 2021 | -60.38% |
| Jun 30, 2021 | -36.46% |